17.11.2014
Na podstawie: D. Farge, P. Debourdeau, M. Beckers, C. Baglin, R.M. Bauersachs, B. Brenner, D. Brilhante, A. Falanga, G.T. Gerotzafias, N. Haim, A.K. Kakkar, A.A. Khorana, R. Lecumberri, M. Mandala, M. Marty, M. Monreal, S.A. Mousa, S. Noble, I. Pabinger, P. Prandoni, M.H. Prins, M.H. Qari, M.B. Streiff, K. Syrigos, H. Bounameaux, H.R. Büller: International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.
P. Debourdeau, D. Farge, M. Beckers, C. Baglin, R.M. Bauersachs, B. Brenner, D. Brilhante, A. Falanga, G.T. Gerotzafias, N. Haim, A.K. Kakkar, A.A. Khorana, R. Lecumberri, M. Mandala, M. Marty, M. Monreal, S.A. Mousa, S. Noble, I. Pabinger, P. Prandoni, M.H. Prins, M.H. Qari, M.B. Streiff, K. Syrigos, H.R. Büller, H. Bounameaux: International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer.
Komentarz: prof. dr hab. n. med. Krystyna Zawilska, Uniwersytet Medyczny im. K. Marcinkowskiego, Centrum Diagnostyczno-Lecznicze INTERLAB w Poznaniu
